Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Neurodegenerative Market Forecast to 2013

Published by: Cutting Edge Information

Published: Feb. 1, 2009 - 201 Pages


Table of Contents


Alzheimer’s

Amyloid Beta Therapies

Bapineuzumab / AAB-001

LY450139

LY2062430

ACC-001

Acetylcholinesterase Inhibitors

Aricept

Excelon

Razadyne

NMDA Antagonists

Namenda: also known as Ebixa in some EU countries

Ebixa: also known as Namenda in US

Other Alzheimer’s Therapies Targeting Neurotransmitters

Abilify

Dimebon

AZD3480 / TC-1734

SB 742457

Other Alzheimer’s Therapies

MEM1003

Tanakan

Avandia XR

Multiple Sclerosis (MS)

Immunomodulators

Copaxone

Fingolimod (FTY720)

BG-12 (Phase III)

Laquinimod (Phase III)

Teriflunomide

Oral Leustatin

Interferon Beta

Avonex

Rebif

Betaferon / Betaseron

Monoclonal antibodies

Rituxan

HuMax CD

Campath

Tysabri

SB683699

Other MS Therapies

Dirucotide (MBP8298)

Fampridine SR

Parkinson’s

Dopamineric drugs

Apokyn

Mirapex

Sinemet

Requip XL

Comtan / Stavelo

Other Drugs

Agilect / Azilect

ACP-103

Droxidopa

Abstract

Which Alzheimer's blockbuster faces diminishing sales within the next decade? What has the potential to take its place? Which class of MS drugs is emerging as successful? What innovative treatments are on the horizon? Who is on track to become a market leader? Neurodegenerative Market Forecast to 2013 answers these questions - and much more - so you can navigate the still-uncharted market landscape with ease. This overview is comprehensive, covering only the most relevant information on Alzheimer's, MS and Parkinson's.....all in one place. With in-depth brand and drug class analyses, make research and spending decisions with the utmost confidence. Other reports skim the surface, examining only top drugs at top companies. Ours is complete, covering marketed brands, pipeline products, clinical development, and whole drug classes. Find all you need to tap into or maximize your presence in this lucrative space.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options

See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2012